2012 annual financial data
Cardiff Oncology 2012 Revenue growth
Direct answer
Revenue growth was 74.62%.
Operating income was -4,849,000 USD and net income was -11,566,000 USD.
Operating cash flow was -4,934,661 USD.
Get free Cardiff Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 450,000 USD
- Operating income
- -4,849,000 USD
- Net income
- -11,566,000 USD
- Operating cash flow
- -4,934,661 USD